BATS BZX Real-Time Price
As of 11:49am ET
| -1.12 / -7.44%|
The 8 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 14.50, with a high estimate of 30.00 and a low estimate of 11.00. The median estimate represents a +4.02% increase from the last price of 13.94.
The current consensus among 8 polled investment analysts is to Hold stock in Clovis Oncology Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.